Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy

Exclusion Criteria

• •1. Other interfering eye diseases
• •2. Presence of any systemic or ocular disease that can cause or likely to cause vision loss
• •3. There is evidence of obviously uncontrolled concomitant diseases
• •4. Known to have active or suspected autoimmune diseases
• •5. With active systemic infection under treatment
• •6. Pregnant or lactating women
• •7. Other conditions unsuitable for the study as determined by the investigator